Related references
Note: Only part of the references are listed.Iodine or Not (IoN) for Low-risk Differentiated Thyroid Cancer: The Next UK National Cancer Research Network Randomised Trial following HiLo
U. Mallick et al.
CLINICAL ONCOLOGY (2012)
Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
Claire Schvartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Radioiodine for Thyroid Cancer - Is Less More?
Erik K. Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
Ujjal Mallick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
Babak Fallahi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Rising Incidence of Second Cancers in Patients With Low-Risk (T1N0) Thyroid Cancer Who Receive Radioactive Iodine Therapy
N. Gopalakrishna Iyer et al.
CANCER (2011)
Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma
Eui Young Kim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Pacini et al.
ANNALS OF ONCOLOGY (2010)
Thyroid Carcinoma
R. Michael Tuttle et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Quality of Life and Effectiveness Comparisons of Thyroxine Withdrawal, Triiodothyronine Withdrawal, and Recombinant Thyroid-Stimulating Hormone Administration for Low-Dose Radioiodine Remnant Ablation of Differentiated Thyroid Carcinoma
Jandee Lee et al.
THYROID (2010)
Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005
Amy Y. Chen et al.
CANCER (2009)
International patterns and trends in thyroid cancer incidence, 1973-2002
Briseis A. Kilfoy et al.
CANCER CAUSES & CONTROL (2009)
Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials
Ashley P. Jones et al.
CLINICAL TRIALS (2009)
Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis
Anna M. Sawka et al.
THYROID (2009)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer
Anna M. Sawka et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study
Hanna O. Maenpaa et al.
PLOS ONE (2008)
Review: I-131 activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review
Allan Hackshaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
PR Schroeder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: A randomized clinical trial in 509 patients
CS Bal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer
AM Sawka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects
S Liu et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
